KeyBanc raised the firm’s price target on Omnicell (OMCL) to $70 from $60 and keeps an Overweight rating on the shares. After a solid Q1, the firm continues to recommend Omnicell as a top idea this year, with plenty of runway ahead, driven by strong pipeline demand from newly-launched Titan XT cabinets. The company reiterated its FY26 bookings guide, and KeyBanc continues to view this as likely conservative, especially at bottom end, given management’s assumption of traditional market share gains this year despite the unique competitive conversion cycle at play.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMCL:
- Analyst Reiterates Buy on Omnicell, Citing Once-in-a-Decade Product Cycle Momentum and Margin Strength; Price Target Maintained at $70
- Omnicell Earnings Call Shows Profits Surging, Outlook Raised
- Omnicell price target raised to $70 from $60 at KeyBanc
- Omnicell reports Q1 adjusted EPS 55c, consensus 33c
- Omnicell sees Q2 adjusted EPS 40c-48c, consensus 42c